查亚叶:糖尿病管理的有希望的方法
Fabiola Curiel Ayala1, Francisco Ignacio García Rodríguez1, Sandra N Jimenez-Garcia2
1División de Ciencias de la Salud, Universidad del Valle de México, Campus Querétaro, Blvd. Juriquilla No. 1000, Santa Rosa Jáuregui, Santiago de Querétaro C.P. 76230, QRO, Mexico.
Pharmaceuticals (Basel, Switzerland)
|September 27, 2025
概括
查亚叶在糖尿病管理方面表现有前途,因为它有可能调节血糖并增强胰岛素分泌. 需要进一步的临床研究来确认其作为补充疗法的益处和安全性.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 叶 (Cnidoscolus aconitifolius) 传统上用于医疗目的.
- 由于其潜在的抗糖尿病特性,科学兴趣越来越大.
- 生物活性化合物如多和黄类是主要的贡献者.
研究的目的:
- 审查最近关于查亚叶的抗糖尿病潜力的科学发现.
- 探索其植物化学特征和拟议的作用机制.
- 总结来自不同类型研究的证据.
主要方法:
- 对过去五年的文献进行系统审查.
- 在数据库中进行的搜索:PubMed,SciELO,ScienceDirect,Dialnet,科学网,谷歌学者.
- 在体内,体外和临床研究数据的分析.
主要成果:
- 柴提取物在动物模型中显示出抗糖尿病作用,包括降糖和抗炎性质.
- 查亚的生物活性化合物可以改善胰岛素敏感性和抗氧化活性.
- 与甲福明的潜在相互作用需要谨慎.
结论:
- 叶可以作为糖尿病管理的有益补充疗法.
- 进一步的临床试验对于阐明机制和制定剂量指南至关重要.
- 临床整合需要对特定化合物和人类安全进行全面的研究.
相关概念视频
Diabetes: Management and Pharmacotherapy
868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Pathophysiology of Diabetes
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Oral Hypoglycemic Agents: Biguanides and Glitazones
585
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
585
Diabetes: Symptoms, Diagnosis, and Complications
2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K


